VF
IMMU

Virtu Financial’s Immunomedics Inc IMMU Stock Holding History

Virtu Financial’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-27,793
Closed -$985K – 1769
2020
Q2 		$985K Buy
+27,793
New +$813K 0.11% 192
2019
Q4 		$244K Sell
11,517
-3,658
-24% -$64.5K 0.02% 810
2019
Q3 		$201K Buy
+15,175
New +$223K 0.02% 971
2019
Q2 		– Sell
-12,516
Closed -$240K – 2036
2019
Q1 		$240K Sell
12,516
-5,494
-31% -$88.6K 0.01% 906
2018
Q4 		$257K Buy
+18,010
New +$358K 0.01% 794
2018
Q2 		– Sell
-22,546
Closed -$329K – 2705
2018
Q1 		$329K Buy
+22,546
New +$368K 0.02% 993

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Virtu Financial's IMMU Position: Q3 2020 in Review

Virtu Financial sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 27,793 shares — an estimated $985K sold.

Virtu Financial first reported a position in IMMU in Q1 2018 and held it in 6 quarters. The position peaked at $985K in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Virtu Financial reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Virtu Financial sold 27,793 Immunomedics Inc shares in Q3 2020, an estimated $985K.
  • Virtu Financial first reported a position in Immunomedics Inc in Q1 2018 and held it in 6 quarters.
  • Virtu Financial's Immunomedics Inc position peaked at $985K in Q2 2020.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Virtu Financial's 13F filing for Q3 2020, filed 11 Dec 2020.